Cargando…

Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know

While early efforts in psychiatry were focused on uncovering the neurobiological basis of psychiatric symptoms, they made little progress due to limited ability to observe the living brain. Today, we know a great deal about the workings of the brain; yet, none of this neurobiological awareness has t...

Descripción completa

Detalles Bibliográficos
Autores principales: Henderson, Theodore A., van Lierop, Muriel J., McLean, Mary, Uszler, John Michael, Thornton, John F., Siow, Yin-Hui, Pavel, Dan G., Cardaci, Joe, Cohen, Phil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176045/
https://www.ncbi.nlm.nih.gov/pubmed/32351416
http://dx.doi.org/10.3389/fpsyt.2020.00276
_version_ 1783524944373612544
author Henderson, Theodore A.
van Lierop, Muriel J.
McLean, Mary
Uszler, John Michael
Thornton, John F.
Siow, Yin-Hui
Pavel, Dan G.
Cardaci, Joe
Cohen, Phil
author_facet Henderson, Theodore A.
van Lierop, Muriel J.
McLean, Mary
Uszler, John Michael
Thornton, John F.
Siow, Yin-Hui
Pavel, Dan G.
Cardaci, Joe
Cohen, Phil
author_sort Henderson, Theodore A.
collection PubMed
description While early efforts in psychiatry were focused on uncovering the neurobiological basis of psychiatric symptoms, they made little progress due to limited ability to observe the living brain. Today, we know a great deal about the workings of the brain; yet, none of this neurobiological awareness has translated into the practice of psychiatry. The categorical system which dominates psychiatric diagnosis and thinking fails to match up to the real world of genetics, sophisticated psychological testing, and neuroimaging. Nevertheless, the American Psychiatric Association (APA) recently published a position paper stating that neuroimaging provided no benefit to the diagnosis and treatment of psychiatric disorders. Using the diagnosis of depression as a model, we illustrate how setting aside the unrealistic expectation of a pathognomonic “fingerprint” for categorical diagnoses, we can avoid missing the biological and, therefore, treatable contributors to psychopathology which can and are visualized using functional neuroimaging. Infection, toxicity, inflammation, gut-brain dysregulation, and traumatic brain injury can all induce psychiatric manifestations which masquerade as depression and other psychiatric disorders. We review these and provide illustrative clinical examples. We further describe situations for which single photon emission computed tomography (SPECT) and positron emission tomography (PET) functional neuroimaging already meet or exceed the criteria set forth by the APA to define a neuroimaging biomarker, including the differential diagnosis of Alzheimer's disease and other dementias, the differential diagnosis of ADHD, and the evaluation of traumatic brain injury. The limitations, both real and perceived, of SPECT and PET functional neuroimaging in the field of psychiatry are also elaborated. An important overarching concept for diagnostic imaging in all its forms, including functional neuroimaging, is that imaging allows a clinician to eliminate possibilities, narrow the differential diagnosis, and tailor the treatment plan. This progression is central to any medical diagnostic process.
format Online
Article
Text
id pubmed-7176045
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71760452020-04-29 Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know Henderson, Theodore A. van Lierop, Muriel J. McLean, Mary Uszler, John Michael Thornton, John F. Siow, Yin-Hui Pavel, Dan G. Cardaci, Joe Cohen, Phil Front Psychiatry Psychiatry While early efforts in psychiatry were focused on uncovering the neurobiological basis of psychiatric symptoms, they made little progress due to limited ability to observe the living brain. Today, we know a great deal about the workings of the brain; yet, none of this neurobiological awareness has translated into the practice of psychiatry. The categorical system which dominates psychiatric diagnosis and thinking fails to match up to the real world of genetics, sophisticated psychological testing, and neuroimaging. Nevertheless, the American Psychiatric Association (APA) recently published a position paper stating that neuroimaging provided no benefit to the diagnosis and treatment of psychiatric disorders. Using the diagnosis of depression as a model, we illustrate how setting aside the unrealistic expectation of a pathognomonic “fingerprint” for categorical diagnoses, we can avoid missing the biological and, therefore, treatable contributors to psychopathology which can and are visualized using functional neuroimaging. Infection, toxicity, inflammation, gut-brain dysregulation, and traumatic brain injury can all induce psychiatric manifestations which masquerade as depression and other psychiatric disorders. We review these and provide illustrative clinical examples. We further describe situations for which single photon emission computed tomography (SPECT) and positron emission tomography (PET) functional neuroimaging already meet or exceed the criteria set forth by the APA to define a neuroimaging biomarker, including the differential diagnosis of Alzheimer's disease and other dementias, the differential diagnosis of ADHD, and the evaluation of traumatic brain injury. The limitations, both real and perceived, of SPECT and PET functional neuroimaging in the field of psychiatry are also elaborated. An important overarching concept for diagnostic imaging in all its forms, including functional neuroimaging, is that imaging allows a clinician to eliminate possibilities, narrow the differential diagnosis, and tailor the treatment plan. This progression is central to any medical diagnostic process. Frontiers Media S.A. 2020-04-15 /pmc/articles/PMC7176045/ /pubmed/32351416 http://dx.doi.org/10.3389/fpsyt.2020.00276 Text en Copyright © 2020 Henderson, van Lierop, McLean, Uszler, Thornton, Siow, Pavel, Cardaci and Cohen http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Henderson, Theodore A.
van Lierop, Muriel J.
McLean, Mary
Uszler, John Michael
Thornton, John F.
Siow, Yin-Hui
Pavel, Dan G.
Cardaci, Joe
Cohen, Phil
Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know
title Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know
title_full Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know
title_fullStr Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know
title_full_unstemmed Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know
title_short Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know
title_sort functional neuroimaging in psychiatry—aiding in diagnosis and guiding treatment. what the american psychiatric association does not know
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176045/
https://www.ncbi.nlm.nih.gov/pubmed/32351416
http://dx.doi.org/10.3389/fpsyt.2020.00276
work_keys_str_mv AT hendersontheodorea functionalneuroimaginginpsychiatryaidingindiagnosisandguidingtreatmentwhattheamericanpsychiatricassociationdoesnotknow
AT vanlieropmurielj functionalneuroimaginginpsychiatryaidingindiagnosisandguidingtreatmentwhattheamericanpsychiatricassociationdoesnotknow
AT mcleanmary functionalneuroimaginginpsychiatryaidingindiagnosisandguidingtreatmentwhattheamericanpsychiatricassociationdoesnotknow
AT uszlerjohnmichael functionalneuroimaginginpsychiatryaidingindiagnosisandguidingtreatmentwhattheamericanpsychiatricassociationdoesnotknow
AT thorntonjohnf functionalneuroimaginginpsychiatryaidingindiagnosisandguidingtreatmentwhattheamericanpsychiatricassociationdoesnotknow
AT siowyinhui functionalneuroimaginginpsychiatryaidingindiagnosisandguidingtreatmentwhattheamericanpsychiatricassociationdoesnotknow
AT paveldang functionalneuroimaginginpsychiatryaidingindiagnosisandguidingtreatmentwhattheamericanpsychiatricassociationdoesnotknow
AT cardacijoe functionalneuroimaginginpsychiatryaidingindiagnosisandguidingtreatmentwhattheamericanpsychiatricassociationdoesnotknow
AT cohenphil functionalneuroimaginginpsychiatryaidingindiagnosisandguidingtreatmentwhattheamericanpsychiatricassociationdoesnotknow